Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Torii Pharmaceutical Co Ltd (4551)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,870.0 +65.0    +1.72%
26/04 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3635800000 
  • Volume: 41,300
  • Bid/Ask: 3,855.0 / 3,870.0
  • Day's Range: 3,760.0 - 3,880.0
Torii Pharmaceutical 3,870.0 +65.0 +1.72%

4551 Balance Sheet

 
Featured here, the Balance Sheet for Torii Pharmaceutical Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 88148 86746 84078 86943
Cash and Short Term Investments 44003 44750 44506 46991
Cash - - - -
Cash & Equivalents 5004 5749 7506 10005
Short Term Investments 38999 39001 37000 36986
Total Receivables, Net 28502 25945 23553 22241
Accounts Receivables - Trade, Net 28502 25945 23553 22241
Total Inventory 10742 10981 10918 10720
Prepaid Expenses 663 - - -
Other Current Assets, Total 4238 5070 5101 6991
Total Assets 133432 132181 131670 129577
Property/Plant/Equipment, Total - Net 2095 2166 2190 2240
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 429 439 459 491
Long Term Investments 41895 42830 44941 39902
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 2 - 2 1
Other Assets, Total 26340 29107 29466 32456
Total Current Liabilities 12504 12705 12020 11408
Accounts Payable 6981 7253 7743 7468
Payable/Accrued - - - -
Accrued Expenses 931 809 408 756
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 222 - - -
Other Current liabilities, Total 4370 4643 3869 3184
Total Liabilities 13299 13587 13005 12510
Total Long Term Debt 22 - - -
Long Term Debt - - - -
Capital Lease Obligations 22 - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 773 882 985 1102
Total Equity 120133 118594 118665 117067
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 5190 5190 5190 5190
Additional Paid-In Capital 6460 6460 6460 6453
Retained Earnings (Accumulated Deficit) 109425 107673 107797 106421
Treasury Stock - Common -1369 -1368 -1368 -1381
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 427 639 586 384
Total Liabilities & Shareholders' Equity 133432 132181 131670 129577
Total Common Shares Outstanding 28.11 28.1 28.1 28.1
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4551 Comments

Write your thoughts about Torii Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email